Vivani Medical, Inc. SEC filings VANI

Vivani Medical, Inc. has 838 filings in SEC EDGAR's recent list, going back to Oct 10, 2003. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Vivani Medical, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Oct 30, 2026 Oct 30, 2026
8-K Current report
Regulation FD disclosure
Oct 29, 2026 Oct 29, 2026
4 Insider transaction Oct 19, 2026 Oct 15, 2026
424B5 Prospectus supplement Sep 25, 2026 —
8-K Current report
Regulation FD disclosure
Sep 16, 2026 Sep 16, 2026
8-K Current report
Regulation FD disclosure
Aug 17, 2026 Aug 17, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2026 Aug 13, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Aug 6, 2026 Aug 6, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 30, 2026 Jul 28, 2026
4 Insider transaction Jul 28, 2026 Jul 27, 2026
4 Insider transaction Jul 16, 2026 Jul 15, 2026
8-K Current report
Regulation FD disclosure
Jul 16, 2026 Jul 15, 2026
8-K Current report
Material agreement, Other events
Jul 7, 2026 Jul 1, 2026
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jun 30, 2026 Jun 24, 2026
4 Insider transaction Jun 26, 2026 Jun 24, 2026
3 Initial insider ownership Jun 26, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 25, 2026 Jun 24, 2026
4 Insider transaction Jun 16, 2026 Jun 15, 2026
8-K Current report
Regulation FD disclosure
Jun 4, 2026 Jun 4, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) May 19, 2026 —
4 Insider transaction May 19, 2026 May 15, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 13, 2026 May 13, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 29, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Dec 31, 2025
4 Insider transaction Apr 16, 2026 Apr 15, 2026
8-K Current report
Results of operations
Mar 26, 2026 Mar 26, 2026
10-K Annual report Mar 26, 2026 Dec 31, 2025
4 Insider transaction Mar 16, 2026 Mar 15, 2026
4 Insider transaction Feb 17, 2026 Feb 15, 2026
4 Insider transaction Jan 28, 2026 Jan 27, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 27, 2026 Jan 25, 2026
424B5 Prospectus supplement Jan 27, 2026 —
4 Insider transaction Jan 20, 2026 Jan 15, 2026
4 Insider transaction Jan 5, 2026 Jan 1, 2026
4 Insider transaction Jan 5, 2026 Jan 1, 2026
4 Insider transaction Dec 31, 2025 Jul 8, 2024
4 Insider transaction Dec 16, 2025 Dec 15, 2025
4 Insider transaction Nov 17, 2025 Nov 15, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2025 Nov 13, 2025
4 Insider transaction Oct 28, 2025 Oct 27, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Oct 28, 2025 Oct 26, 2025
424B5 Prospectus supplement Oct 28, 2025 —
4 Insider transaction Oct 16, 2025 Oct 15, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 3, 2025 Oct 3, 2025
4 Insider transaction Sep 17, 2025 Sep 15, 2025
8-K Current report
Other events
Sep 17, 2025 Sep 17, 2025
8-K Current report
Regulation FD disclosure
Sep 9, 2025 Sep 9, 2025
8-K Current report
Other events
Sep 4, 2025 Sep 4, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
Aug 13, 2025 Aug 11, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Aug 5, 2025 Aug 5, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
4 Insider transaction Jun 26, 2025 Jun 24, 2025
8-K Current report
Shareholder vote results
Jun 25, 2025 Jun 24, 2025
4 Insider transaction Jun 17, 2025 Jun 15, 2025
3 Initial insider ownership Jun 17, 2025 Jun 15, 2025
8-K Current report
Regulation FD disclosure
Jun 17, 2025 Jun 17, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 11, 2025 Jun 11, 2025
8-K Current report
Other events
May 29, 2025 May 29, 2025
4 Insider transaction May 16, 2025 May 14, 2025
4 Insider transaction May 14, 2025 May 12, 2025
4 Insider transaction May 14, 2025 May 12, 2025
4 Insider transaction May 14, 2025 May 12, 2025
4 Insider transaction May 14, 2025 May 12, 2025
4 Insider transaction May 14, 2025 May 12, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
May 13, 2025 May 12, 2025
DEFR14A Filing May 6, 2025 —
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 24, 2025
4 Insider transaction Apr 28, 2025 Apr 24, 2025
4 Insider transaction Apr 23, 2025 Apr 21, 2025
8-K Current report
Other events
Apr 15, 2025 Apr 12, 2025
4 Insider transaction Apr 11, 2025 Apr 9, 2025
4 Insider transaction Apr 8, 2025 Apr 4, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
4 Insider transaction Apr 1, 2025 Apr 1, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 31, 2025 Mar 31, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Mar 27, 2025 Mar 26, 2025
8-K Current report
Other events
Mar 26, 2025 Mar 26, 2025
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Mar 13, 2025 Mar 13, 2025
4 Insider transaction Mar 3, 2025 Feb 28, 2025
4 Insider transaction Jan 3, 2025 Jan 1, 2025
4 Insider transaction Jan 3, 2025 Jan 1, 2025
4 Insider transaction Nov 13, 2024 Nov 8, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2024 Nov 13, 2024
8-K Current report
Other events
Oct 22, 2024 Oct 22, 2024
4 Insider transaction Oct 3, 2024 Oct 1, 2024
8-K Current report
Other events
Sep 26, 2024 Sep 26, 2024
8-K Current report
Other events
Sep 23, 2024 Sep 23, 2024
8-K Current report
Other events
Sep 4, 2024 Sep 4, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2024 Aug 13, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
4 Insider transaction Aug 1, 2024 Jul 30, 2024
4 Insider transaction Aug 1, 2024 Nov 22, 2023
8-K Current report
Other events
Jul 11, 2024 Jul 11, 2024
4 Insider transaction Jul 1, 2024 Jun 27, 2024
4 Insider transaction Jul 1, 2024 Jun 27, 2024
4 Insider transaction Jul 1, 2024 Jun 27, 2024
4 Insider transaction Jul 1, 2024 Jun 27, 2024
4 Insider transaction Jul 1, 2024 Jun 27, 2024
8-K Current report
Shareholder vote results
Jun 28, 2024 Jun 28, 2024
8-K Current report
Other events
Jun 13, 2024 Jun 7, 2024
4 Insider transaction May 14, 2024 May 10, 2024
4 Insider transaction May 14, 2024 May 10, 2024
4 Insider transaction May 14, 2024 May 10, 2024
4 Insider transaction May 14, 2024 May 10, 2024
4 Insider transaction May 14, 2024 May 10, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 13, 2024 May 13, 2024
EFFECT Filing May 3, 2024 —
CORRESP Letter to the SEC May 2, 2024 —
S-3/A Filing May 2, 2024 —
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 27, 2024
UPLOAD Letter from the SEC Apr 29, 2024 —
8-K Current report
Material agreement
Apr 23, 2024 Apr 22, 2024
S-3 Shelf registration Apr 22, 2024 —
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
10-K Annual report Mar 26, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Mar 26, 2024 Mar 26, 2024
3 Initial insider ownership Mar 11, 2024 Mar 4, 2024
8-K Current report
Officer or director change
Mar 6, 2024 Mar 4, 2024
8-K Current report
Material agreement, Regulation FD disclosure
Mar 5, 2024 Mar 1, 2024
424B5 Prospectus supplement Mar 5, 2024 —
144 Notice of proposed sale Mar 5, 2024 —
8-K Current report
Regulation FD disclosure
Feb 28, 2024 Feb 28, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 9, 2024 Feb 8, 2024
4 Insider transaction Feb 6, 2024 Feb 5, 2024
4 Insider transaction Feb 2, 2024 Jan 31, 2024
4 Insider transaction Jan 25, 2024 Jan 23, 2024
4 Insider transaction Jan 22, 2024 Jan 22, 2024
4 Insider transaction Jan 19, 2024 Jan 18, 2024
4 Insider transaction Jan 16, 2024 Jan 16, 2024
8-K Current report
Other events
Jan 10, 2024 Jan 9, 2024
4 Insider transaction Jan 9, 2024 Jan 8, 2024
4 Insider transaction Jan 5, 2024 Jan 4, 2024
4 Insider transaction Jan 3, 2024 Jan 2, 2024
4 Insider transaction Dec 27, 2023 Dec 22, 2023
8-K Current report
Listing notice
Dec 27, 2023 Dec 26, 2023
4 Insider transaction Dec 21, 2023 Dec 19, 2023
4 Insider transaction Dec 18, 2023 Dec 14, 2023
4 Insider transaction Dec 18, 2023 Dec 15, 2023
4 Insider transaction Dec 13, 2023 Dec 11, 2023
4 Insider transaction Dec 8, 2023 Dec 6, 2023
4 Insider transaction Nov 27, 2023 Nov 22, 2023
8-K Current report
Officer or director change
Nov 24, 2023 Nov 20, 2023
4 Insider transaction Nov 22, 2023 Nov 20, 2023
4 Insider transaction Nov 20, 2023 Nov 16, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 14, 2023 Nov 14, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
4 Insider transaction Oct 24, 2023 Oct 20, 2023
4 Insider transaction Oct 16, 2023 Oct 12, 2023
4 Insider transaction Oct 11, 2023 Oct 9, 2023
4 Insider transaction Oct 10, 2023 Oct 6, 2023
4 Insider transaction Oct 5, 2023 Oct 3, 2023
4 Insider transaction Oct 2, 2023 Sep 28, 2023
4 Insider transaction Sep 27, 2023 Sep 27, 2023
4 Insider transaction Sep 27, 2023 Sep 25, 2023
4 Insider transaction Sep 22, 2023 Sep 20, 2023
4 Insider transaction Sep 18, 2023 Sep 14, 2023
8-K Current report
Regulation FD disclosure
Sep 18, 2023 Sep 15, 2023
4 Insider transaction Sep 12, 2023 Sep 8, 2023
4 Insider transaction Sep 7, 2023 Sep 5, 2023
4 Insider transaction Sep 5, 2023 Aug 31, 2023
4 Insider transaction Sep 5, 2023 Aug 31, 2023
4 Insider transaction Sep 1, 2023 Aug 31, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Aug 29, 2023 Aug 25, 2023
4 Insider transaction Aug 18, 2023 Aug 17, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Jul 10, 2023 Jul 5, 2023
4 Insider transaction Jun 29, 2023 Jun 27, 2023
4 Insider transaction Jun 26, 2023 Jun 22, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
4 Insider transaction Jun 20, 2023 Jun 15, 2023
8-K Current report
Shareholder vote results
Jun 16, 2023 Jun 15, 2023
4 Insider transaction Jun 12, 2023 Jun 9, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 15, 2023 May 15, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
VANI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Alameda, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1266806
Former names
SECOND SIGHT MEDICAL PRODUCTS INC (until Aug 18, 2022); SECOUND SIGHT MEDICAL PRODUCTS INC (until Oct 10, 2003)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.